Literature DB >> 20089417

Should we neglect or nurture replacement blood donors in sub-Saharan Africa?

Imelda Bates1, Oliver Hassall.   

Abstract

Lack of blood is common in SSA but quantification of the overall shortfall is hampered by a lack of evidence-based targets for blood collection. Despite recommendations that all blood donors should be voluntary and non-remunerated, replacement donors are common throughout sub-Saharan Africa (SSA). Voluntary donors are generally recruited through centralised systems whereas replacement donors are recruited by families and donate through hospitals. Blood from a centralised service is more expensive than from a hospital-based service due to the higher costs of donor recruitment, quality assurance processes and the maintenance of distribution networks. Information about the contribution of replacement donors to the blood supply is scanty and inconsistent but it is likely that they currently provide over half of the blood in SSA. WHO's guidelines for transfusion services deal exclusively with voluntary donors and neglect the substantial contribution made by replacement donors. Examples of how the supply and quality of blood from the replacement donors can be improved have been published but need to be evaluated and disseminated. Political will and open-mindedness to innovative ways to improve supply and safety of blood from all types of donors are essential to promote more evidence-based approaches to blood transfusion practice in low-income countries. Copyright 2009. Published by Elsevier Ltd.

Entities:  

Mesh:

Year:  2010        PMID: 20089417     DOI: 10.1016/j.biologicals.2009.10.013

Source DB:  PubMed          Journal:  Biologicals        ISSN: 1045-1056            Impact factor:   1.856


  9 in total

Review 1.  Blood transfusion safety in Africa: a literature review of infectious disease and organizational challenges.

Authors:  Evan M Bloch; Marion Vermeulen; Edward Murphy
Journal:  Transfus Med Rev       Date:  2011-08-26

2.  Prevalence of Human Immunodeficiency Virus Transmission among Transfused Children with Sickle Cell Anemia in Enugu Nigeria.

Authors:  Ac Ubesie; Ij Emodi; An Ikefuna; Gc Ilechukwu; Gca Ilechukwu
Journal:  Ann Med Health Sci Res       Date:  2012-07

3.  Implications of confidential unit exclusion in providing sufficient safe blood for the national health system.

Authors:  Abdol Majid Cheraghali
Journal:  Hepat Mon       Date:  2011-11-30       Impact factor: 0.660

4.  The challenges of meeting the blood transfusion requirements in Sub-Saharan Africa: the need for the development of alternatives to allogenic blood.

Authors:  Erhabor Osaro; Adias Teddy Charles
Journal:  J Blood Med       Date:  2011-02-06

5.  Blood safety concerns in the Eastern Mediterranean region.

Authors:  Abdol Majid Cheraghali
Journal:  Hepat Mon       Date:  2011-06       Impact factor: 0.660

Review 6.  Family donors are critical and legitimate in developing countries.

Authors:  Jean-Pierre Allain; Cees Th Smit Sibinga
Journal:  Asian J Transfus Sci       Date:  2016 Jan-Jun

7.  The global surgery blood drought: frontline provider data on barriers and solutions in Bihar, India.

Authors:  Rachita Sood; Rachel R Yorlets; Nakul P Raykar; Remya Menon; Hemant Shah; Nobhojit Roy
Journal:  Glob Health Action       Date:  2019       Impact factor: 2.640

8.  Voluntary and non-voluntary blood donations among doctors.

Authors:  Rana Ahmed Saleh; Hala Khalil; Mahasen Alsaleh; Amani Almeharish; Viqaruddin Mohammed; Hind Alhumaidan; Renad Saleh
Journal:  Health Sci Rep       Date:  2021-10-05

9.  External financial aid to blood transfusion services in sub-Saharan Africa: a need for reflection.

Authors:  Fereydoun Ala; Jean-Pierre Allain; Imelda Bates; Kamel Boukef; Frank Boulton; James Brandful; Elizabeth M Dax; Magdy El Ekiaby; Albert Farrugia; Jed Gorlin; Oliver Hassall; Helen Lee; André Loua; Kathryn Maitland; Dora Mbanya; Zainab Mukhtar; William Murphy; Ohene Opare-Sem; Shirley Owusu-Ofori; Henk Reesink; David Roberts; Oscar Torres; Grace Totoe; Henrik Ullum; Silvano Wendel
Journal:  PLoS Med       Date:  2012-09-11       Impact factor: 11.069

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.